![](/img/cover-not-exists.png)
2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part
Hebbar, M., Heurgue-Berlot, A., Boige, V., Le Malicot, K., Bernard-Chabert, B., Marcus, C., Dharancy, S., Sergent, G., Perarnau, J.M., Ehrhard, F., Ollivier-Hourmand, I., Vergniol, J., Michel, P., EdeVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31221-7
Date:
September, 2015
File:
PDF, 60 KB
english, 2015